Skip to main content
SpringerLink
Log in

Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: A marker of cardiac dilatation

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Background: Idiopathic dilated cardiomyopathy (DCM), ventricular systolic dysfunction and chamber dilatation are accompanied by architectural remodeling, wall thinning and cardiac myocyte slippage. Recent work has demonstrated an association between collagen degradation and an increased expression of matrix metalloproteinases (MMPs). Accordingly, we have sought to correlate (a) collagen degradation with MMP elevations and, (b) assay the neutralizing potential of a known inhibitor of MMP, tetracycline on MMPs in DCM. Methods: Assessment of LV volume and shape by 2-D echocardiography was performed. Light microscopic assessment of histopathology in picrosirius red stained biopsy samples of 11 DCM patients and six post-transplant patients was performed. Zymographic estimation of MMP activity and influence of tetracycline on MMP activity was assessed. Results: Small amount of interstitial collagen was noted in the control group, whereas in the DCM hearts, chamber dilatation was associated with areas of scanty myocyte necrosis, islands of excess collagen, and focal areas of absent or scanty collagen with intact myocytes. In cardiomyopathic tissue, collagenase activity was markedly elevated at 63% compared with 8% in post-transplant tissue. Tetracycline at a concentration of 285 ± 10 μM (IC50) inhibited collagenase activity by 50% in cardiomyopathic tissue. Conclusions: Areas of focal interstitial collagen accumulation were accompanied by collagen fiber lysis and increased collagenase activity in dilated cardiomyopathy. This enhanced collagenolytic activity found in endomyocardial biopsy tissue was inhibited by tetracycline. The non-antibiotic property of tetracycline may be of potential value in the prevention of ventricular dilatation in idiopathic dilated cardiomyopathy. (Mol Cell Biochem 264: 183–191, 2004)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bohm M, Gierschik P, Jakobs KH, Schnabel P, Kemkes B, Erdmann E: Localization of a "postreceptor" defect in human dilated cardiomyopathy. Am J Cardiol 64: 812–816, 1989

    Article  PubMed  Google Scholar 

  • Limas CJ, Goldenberg IF, Limas C: Influence of anti-beta receptor anti-bodies on cardiac adenylate cyclase in patients with idiopathic dilated cardiomyopathy. Am Heart J 119: 1322–1327, 1990

    PubMed  Google Scholar 

  • Spinale FG, Coker ML, Thomas CV, Walker JD, Mukherjee R, Hebbar L: Time dependent changes in matrix metalloproteinase activity and ex-pression during the progression of congestive heart failure. Circ Res 82: 482–495, 1998

    PubMed  Google Scholar 

  • Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ: Matrixmet-alloproteinase activity expression in infarcted, non-infarcted and di-lated cardiomyopathic human hearts. Mol Cell Biochem 155: 13–21, 1996

    Article  PubMed  Google Scholar 

  • Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ, Spinale FG: Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circ 97: 1708–1715, 1998

    Google Scholar 

  • Li YY, Feldman AM, Sun Y, McTiernan CF: Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circ 98: 1728–1734, 1998

    Google Scholar 

  • D'Cruz IA, Shroff SG, Janicki JS, Jain A, Reddy HK, Lakier JB: Differences in the shape of the normal, cardiomyopathic, and volume overloaded hu-man left ventricle. J Am Soc Echo 2: 408–414, 1989

    Google Scholar 

  • Wyatt HL, Heng MK, Meerbaum S: Cross-sectional echocardiography II: Analysis of mathematical models for quantifying volume of the formalin-fixed left ventricle. Circulation 61: 1119–1125, 1980

    PubMed  Google Scholar 

  • Tyagi SC, Ratajska A, Weber KT: Myocardial matrix metalloproteinases: Localization and activation. Mol Coll Biochem 126: 49–59, 1993

    Google Scholar 

  • Weber KT: Cardiac interstitium in health and disease: The fibrillar collagen network. J Am Coll Cardiol 13: 1637–1652, 1989

    PubMed  Google Scholar 

  • Olivetti G, Capasso JM, Sonnenblick EH, Anversa P: Side to side slippage of myocytes participates in ventricular wall remodeling acutely after my-ocardial infarction in rats. Cir Res 67: 23–34, 1990

    Google Scholar 

  • Weber KT, Pick R, Janicki JS, Gadodia G, Lakier JB: Inadequate col-lagen tethers in dilated cardiopathy. Am Heart J 116: 1641–1646, 1988

    Article  PubMed  Google Scholar 

  • Motz W, Strauer BE: Left ventricular function and collagen content af-ter regression of hypertensive hypertrophy. Hypertension 34: 43–50, 1989

    Google Scholar 

  • Weber KT, Pick R, Silver MA, Moe GW, Janicki JS, Zucker IH, Armstrong PW: Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation 82: 1387–1401, 1990

    PubMed  Google Scholar 

  • Cannon RO, Butany JW, McManus BM, Speir E, Kravits AB, Billi R, Ferrans VJ: Early degradation of collagen after acute myocardial infarc-tion in the rat. Am J Cardiol 52: 390–395, 1983

    Article  PubMed  Google Scholar 

  • Armstrong PW, Moe GW, Howard RJ, Grima EA, Cruz TF: Structural re-modeling in heart failure: Gelatinase induction. Can J Cardiol 10(2): 214–220, 1994

    PubMed  Google Scholar 

  • Weber KT, Sun Y, Tyagi SC, Cleutjens J: Collagen network of the my-ocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26: 279–292, 1994

    Article  PubMed  Google Scholar 

  • Borg TK, Caulfield JB: The collagen matrix of the heart. Fed Proc 40: 2037–2041, 1981

    PubMed  Google Scholar 

  • Borg TK, Sullivan T, Ivy J: Functional arrangement of connective tissue in striated muscle with emphasis on cardiac muscle. SEM IV: 1775–1784, 1982

    Google Scholar 

  • Yoshikane H, Honda M, Goto Y, Morioka S, Ooshima A, Moriyama K: Collagen in dilated cardiomyopathy. Jpn Circ J 56: 899–910, 1992

    Google Scholar 

  • Maisch N, Bauer E, Hufnagel G: The use of endomyocardial biopsy in heart failure. Eur Heart J 9: 59–64, 1988

    Google Scholar 

  • Popma JJ, Cigarroa RG, Buja LM, Hillis LD: Diagnostic and prognostic util-ity of right-sided catheterization and endomyocardial biopsy in idiopathic dilated cardiomyopathy. Am J Cardiol 63: 955–958, 1989

    PubMed  Google Scholar 

  • Spinale FG, Tomita M, Zellner JL, Cook JC, Crawford FA, Zile MR: Collagen cemodeling and changes in LV function during the development and recovery from supraventricular tachycardia. Am J Phys-iol 261: H308–H318, 1991

    Google Scholar 

  • Montfort I, Perez-Tamayo R: The distribution of collagenase in normal rat tissues. J Histochem Cytochem 23: 910–920, 1975

    PubMed  Google Scholar 

  • Charney RH, Takahashi S, Zhao M, Sonnenblick EH, Eng C: Collagen loss in the stunned myocardium. Circulation 85: 1483–1490, 1992

    PubMed  Google Scholar 

  • Sorsa T, Konttinen YT, Lindy O, Suomalainen K, Ingman T, Saari H, Ha-linen S, Lee HM, Golub LM, Hall J: Doxycycline protects serum alpha-1-antitrypsin from human neutrophil collagenase. Agents & Actions-Supplements 39: 225–229, 1993

    Google Scholar 

  • Chowdury MH, Moak SA, Rifkin BR, Greenwald RA: Effect of tetracyclines which have metalloproteinase inhibitory capacity on basal and heparin-stimulated bone resorption by chick osteoclasts. Agents & Actions 40(1-2): 124–128, 1993

    Google Scholar 

  • Breedveldt FC, Dijkmans BAC, Mattie H: Minocycline treatment for rheumatoid arthritis: An open dose finding study. J Rheumatol 17: 43–46, 1990

    PubMed  Google Scholar 

  • Golub LM, Ciancio S, Ramamurthy, Leung M, McNamara TF: The effect of low dose doxycycline on human gingival and crevicular fluid collagenase. J Periodontal Res 25: 321–330, 1990

    PubMed  Google Scholar 

  • Humbert P, Renaud A, Laurent R, Agache P: Tetracyclines for dystrophic epidermolysis bullosa. Lancet 1: 277–282, 1989

    Article  Google Scholar 

  • White JE: Minocycline for dystrophic epidermolysis bullosa. Lancet 1: 966–971, 1989

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Internal Medicine, University of Missouri-Columbia, MO, USA

    Hanumanth K. Reddy, Imam E. Tjahja & Scott E. Campbell

  2. Auburn University, Auburn, AL, USA

    Joseph S. Janicki

  3. Department of Family and Community Medicine, University of Missouri-Columbia, MO, USA

    Melvin R. Hayden

  4. Department of Physiology & Biophysics, School of Medicine, University of Louisville, Louisville, KY, USA

    Suresh C. Tyagi

Authors
  1. Hanumanth K. Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Imam E. Tjahja
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott E. Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joseph S. Janicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Melvin R. Hayden
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Suresh C. Tyagi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reddy, H.K., Tjahja, I.E., Campbell, S.E. et al. Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: A marker of cardiac dilatation. Mol Cell Biochem 264, 183–191 (2004). https://doi.org/10.1023/B:MCBI.0000044387.04670.81

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000044387.04670.81

Search

Navigation